Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)
- DOI
- 10.1080/2162402x.2017.1368605
- Published
- 2017-09-21
- Container
- OncoImmunology
- Publisher
- Informa UK Limited
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1080/2162402x.2017.1368605,
title = {Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB)},
author = {Arantza Azpilikueta and Elixabet Bolaños and Valerie Lang and Sara Labiano and Maria A. Aznar and Iñaki Etxeberria and Alvaro Teijeira and Maria E. Rodriguez-Ruiz and Jose L. Perez-Gracia and Maria Jure-Kunkel and Juan M. Zapata and Manuel S. Rodriguez and Ignacio Melero},
year = {2017},
journal = {OncoImmunology},
doi = {10.1080/2162402x.2017.1368605},
url = {https://doi.org/10.1080/2162402x.2017.1368605}
}RIS
TY - JOUR TI - Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB) AU - Arantza Azpilikueta AU - Elixabet Bolaños AU - Valerie Lang AU - Sara Labiano AU - Maria A. Aznar AU - Iñaki Etxeberria AU - Alvaro Teijeira AU - Maria E. Rodriguez-Ruiz AU - Jose L. Perez-Gracia AU - Maria Jure-Kunkel AU - Juan M. Zapata AU - Manuel S. Rodriguez AU - Ignacio Melero PY - 2017 JO - OncoImmunology DO - 10.1080/2162402x.2017.1368605 UR - https://doi.org/10.1080/2162402x.2017.1368605 ER -
APA
Azpilikueta, A., Bolaños, E., Lang, V., Labiano, S., Aznar, M. A., Etxeberria, I., Teijeira, A., Rodriguez-Ruiz, M. E., Perez-Gracia, J. L., Jure-Kunkel, M., Zapata, J. M., Rodriguez, M. S., & Melero, I. (2017). Deubiquitinases A20 and CYLD modulate costimulatory signaling via CD137 (4–1BB). OncoImmunology. https://doi.org/10.1080/2162402x.2017.1368605
Source records
- crossref · retrieved 2026-09-27T01:31:46.864Z